CINRX PHARMA
CinRx Pharma was launched in September of 2015 to transform the development of innovative therapies addressing substantial unmet medical needs. With leading CRO Medpace as a strategic partner, CinRx leverages its cost-efficient structure while having access to global clinical development expertise and networks of advisors, critical understanding of the evolving regulatory environment, and industry-leading track records of execution across all stages of R&D. CinRxโs therapeutic pipeline focuse... s on innovative and disruptive new molecular entities (NMEs). CinRx pursues an expedited path of development to achieve significant value inflection points for each of its programs. Once a compound has demonstrated clinical and commercial value, CinRx will determine the optimal strategy to bring the product to patients.
CINRX PHARMA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2015-09-01
Status:
Active
Contact:
844-531-1834
Email Addresses:
[email protected]
Total Funding:
38.41 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Euro WordPress 6.0 WPBakery ThemePunch
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
kancera
Kancera carries out pharmaceutical development,
OncoQuest
OncoQuest is a Edmonton-based biopharmaceutical company.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-10-12 | CinCor Pharma | CinRx Pharma investment in Series B - CinCor Pharma | 143 M USD |